| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
| 2924 | | Carboxyamide-function compounds; amide-function compounds of carbonic acid: | | | | |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.21.04 | 00 | 3-(p-Chlorophenyl)-1,1-dimethylurea (Monuron) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 40.5% |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-¢/tolyl)urea (Fluometuron) | kg | Free | | 15.4¢/kg + 40.5% |
| 2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 53% |
| 2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4¢/kg + 58% |
| 2924.29.28 | 00 | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6- difluorobenzamide; and 3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)- benzamide (Pronamide) | kg | Free | | 15.4¢/kg + 64.5% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-¢/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
| 2924.29.43 | 00 | 3-Ethoxycarbonylaminophenyl-¢/phenylcarbamate (Desmedipham); and Isopropyl-N-(3-chlorophenyl)car- bamate (CIPC) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 40.5% |
| 2924.29.71 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2925 | | Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds: | | | | |
| 2925.29.18 | 00 | N,N'-Diphenylguanidine; 3-Dimethylaminomethyleneiminophenol hydrochloride; 1,3-Di-o-tolylguanidine; and N,N-Dimethyl-N'-[3-[[(methylamino)carbonyl]- oxy]phenyl]methanimidamide monohydro- chloride | kg | Free | | 15.4¢/kg + 61% |
| 2926 | | Nitrile-function compounds: | | | | |
| 2926.10.00 | 00 | Acrylonitrile | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 56.5% |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.90.05 | 00 | 2-Amino-4-chlorobenzonitrile (5-Chloro-2- cyanoaniline); 2-Amino-5-chlorobenzonitrile; 4-Amino-2-chlorobenzonitrile; (Cyanoethyl)(hydroxyethyl)-m-toluidine; p-Cyanophenyl acetate; Phthalonitrile; and Tetrachloro-3-cyanobenzoic acid, methyl ester | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 41% |
| 2926.90.08 | 00 | Benzonitrile | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 41% |
| 2926.90.11 | 00 | Dichlorobenzonitriles: | | | | |
| 2926.90.11 | 00 | 2,6-Dichlorobenzonitrile | kg | Free | | 15.4¢/kg + 41% |
Harmonized Tariff Schedule of the United States inquiry: gaming
